Aaron Lazar on his ALS Journey and The Impossible Dream
Dr. Bedlack discusses how he helps his patients find hope in their ALS journeys while also making realistic plans for the future.
Bedlack Recipient of Inaugural Accelerate a Miracle Project Award
Richard Bedlack, MD, PhD has been named as the inaugural recipient of the Accelerate a Miracle Project (or AMP) Award by the Hop on a Cure Foundation.
Study Finds Genetic Variant Among People Who Experience a Rare Recovery from ALS
Read more about a study co-lead by Dr. Bedlack regarding ALS recovery.
A neurologist took DIY treatments seriously. Has it sparked a breakthrough?
Dr. Bedlack discusses ALSUntangled — a group dedicated to investigating alleged or emerging ALS treatments.
This woman has ALS. So did 22 of her relatives. What she wants you to know.
Dr. Bedlack comments on the use of Qalsody and its impact on ALS patients with the SOD1 gene.
Poor Results in a Phase 3 Trial Deal a Blow to a Promising, Controversial ALS Drug
Dr. Bedlack provides perspective on the results of the ALS drug trial for AMX005.
Duke Neurology Research Round Up, December 2023
The final month of 2023 saw members of the Duke Neurology Department contributing to nine new peer-reviewed journal articles. Highlights include an analysis of symptoms associated with internal tremor for Parkinson’s disease, a trio of population-level studies for stroke, and a new examination of the connections between white matter and executive function. Read short summaries of each of these articles and find links to the original research below.
Duke Neurology Research Round Up, December 2023
What do a speech prosthetic that translates brain signals into speech, retinal scans that detect cognitive impairment, and a promising new form of genetic therapy for Parkinson’s and some forms of dementia have in common? They’re all examples of the 21 peer-reviewed journal articles authored members of the Duke Neurology Department published this November.
Duke Neurology Research Round Up, October 2023
The month of September saw 20 new peer-reviewed journal articles articles and one book chapter from members of the Duke Neurology Department.
Faculty Spotlight: Jonathan Morena, DO
When Ohio State University launched its neuroscience program just over a decade ago, Jonathan Morena, DO, was one of its first and most enthusiastic enrollees. Shortly afterwards, an experience as a camp counselor in a local MDA clinic convinced him to specialize in neuromuscular disorders. Now, Morena is the newest addition to our division of neuromuscular disorders.